Stereochemistry as a diversity element: Solid-phase synthesis of cyclic RGD peptide derivatives by asymmetric catalysis

Angewandte Chemie - International Edition

Volumn 37, Issue 13-14, 1998, Pages 1907-1909

  Annis, D Allen ^a   Helluin, Olivier ^b   Jacobsen, Eric N ^a  

^a HARVARD UNIVERSITY   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Asymmetric catalysis; Combinatorial chemistry; Macrocycles; Solid phase synthesis

Indexed keywords

EID: 0032479797     PISSN: 14337851     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-3773(19980803)37:13/14<1907::AID-ANIE1907>3.0.CO;2-A     Document Type: Article

References (26)

1. a) M. A. Gallop, R. W. Barrett, W. J. Dower, S. P. A. Fodor, E. M. Gordon, J. Med. Chem. 1994, 37, 1233-1251;
2. b) E. M. Gordon, R. W. Barrett, W. J. Dower, S. P. A. Fodor, M. A. Gallop, ibid. 1994, 37, 1385-1401;
3. c) L. A. Thompson, J. A. Ellman, Chem. Rev. 1996, 96, 555-600.
4. Reviews of solid-phase organic reactions: a) P. H. H. Hermkens, H. C. J. Ottenheijm, D. Rees, Tetrahedron 1996, 52, 4527-4554; b) P. H. H. Hermkens, H. C. J. Ottenheijm, D. Rees, ibid. 1997, 53, 5643-5678.
5. Reviews of solid-phase organic reactions: a) P. H. H. Hermkens, H. C. J. Ottenheijm, D. Rees, Tetrahedron 1996, 52, 4527-4554; b) P. H. H. Hermkens, H. C. J. Ottenheijm, D. Rees, ibid. 1997, 53, 5643-5678.
6. a) M. Reggelin, V. Brenig, Tetrahedron Lett. 1996, 37, 6851-6852;
7. b) J. S. Panek, B. Zhu, J. Am. Chem. Soc. 1997, 119, 12022-12023, and references therein.
8. For applications of asymmetric catalysis to polymer-immobilized substrates, see a) I. Ojima, C-Y. Tsai, Z. Zhang, Tetrahedron Lett. 1994, 35, 5785-5788; b) H. Han, K. D. Janda, Angew. Chem. 1997, 109, 1835-1937; Angew. Chem. Im. Ed. Engl. 1997, 36, 1731-1733.
9. For applications of asymmetric catalysis to polymer-immobilized substrates, see a) I. Ojima, C-Y. Tsai, Z. Zhang, Tetrahedron Lett. 1994, 35, 5785-5788; b) H. Han, K. D. Janda, Angew. Chem. 1997, 109, 1835-1937; Angew. Chem. Im. Ed. Engl. 1997, 36, 1731-1733.
10. For applications of asymmetric catalysis to polymer-immobilized substrates, see a) I. Ojima, C-Y. Tsai, Z. Zhang, Tetrahedron Lett. 1994, 35, 5785-5788; b) H. Han, K. D. Janda, Angew. Chem. 1997, 109, 1835-1937; Angew. Chem. Im. Ed. Engl. 1997, 36, 1731-1733.
11. a) M. Aumailly, M. Gurrath, G. Muller, J. Calvete, R. Timpl, H. Kessler, FEBS Lett. 1991, 291, 50-54;
12. b) M. Pfaff, K. Tangemann, B. Muller, M. Gurrath, G. Muller, H. Kessler, R. Timpl, J. Engel, J. Biol. Chem. 1994, 269, 20233-20238;
13. c) A. C. Bach II, J. R. Espina, S. A. Jackson, P. F. W. Stouten, J. L. Duke, S. A. Mousa, W. F. DeGrado, J. Am. Chem. Soc. 1996, 118, 293-294.
14. The endogenous targets of RGD sequences, whose members include the integrin family of receptors, are currently of great interest for the development of antithrombotic, antimetastatic, and anti-angiogenesis drug candidates, provided selectivity between these targets can be realized. For a timely review, see R. Haubner, D. Finsinger, H. Kessler, Angew. Chem. 1997, 109, 1440-1456; Angew. Chem. Int. Ed. Engl. 1997, 36, 1374-1389.
15. The endogenous targets of RGD sequences, whose members include the integrin family of receptors, are currently of great interest for the development of antithrombotic, antimetastatic, and anti-angiogenesis drug candidates, provided selectivity between these targets can be realized. For a timely review, see R. Haubner, D. Finsinger, H. Kessler, Angew. Chem. 1997, 109, 1440-1456; Angew. Chem. Int. Ed. Engl. 1997, 36, 1374-1389.
16. a) L. E. Martínez, J. L. Leighton, D. H. Carsten, E. N. Jacobsen, J. Am. Chem. Soc. 1995, 117, 5897-5898;
17. b) S. E. Schaus, J. F. Larrow, E. N. Jacobsen, J. Org. Chem. 1997, 62, 4197-4199.
18. Wang-type polystyrene resin with grafted poly(ethylene glycol) units, from which the bound compounds can be removed by acid cleavage. Advanced ChemTech, 5609 Fern Valley Rd., Louisville, KY 40228 (USA).
19. J. L. Leighton, E. N. Jacobsen, J. Org. Chem. 1996, 61, 389-90.
20. Premixing of the phosphane, azodicarboxylate ester, and carboxylic acid was neccesary to prevent undesired reaction of the phosphane with polymer-bound azide: D. Crich, H. Dyker, R. J. Harris, J. Org. Chem. 1989, 54, 257-259.
21. a) Azide reduction: E. K. Kick, J. A. Ellman, J. Med. Chem. 1995, 38, 1427-1430; reduction of the cis azido tripeptide esters 10 was accompanied by acyl migration: G. Bellucci, R. Bianchini, C. Chiappe, J. Org. Chem. 1991, 56, 3067-3073
22. a) Azide reduction: E. K. Kick, J. A. Ellman, J. Med. Chem. 1995, 38, 1427-1430; reduction of the cis azido tripeptide esters 10 was accompanied by acyl migration: G. Bellucci, R. Bianchini, C. Chiappe, J. Org. Chem. 1991, 56, 3067-3073
23. b) macrocyclization was achieved with Carpino's HATU reagent (O-(7-azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate): L. A. Carpino, J. Am. Chem. Soc. 1993, 115, 4397-4398.
24. C. E. Peishoff, J. W. Bean, K. D. Kopple, J. Am. Chem. Soc. 1991, 113, 4416-4421.
25. 3 were established by quantifying the inhibition of agonist-stimulated platelet adherence to immobilized osteopontin and fibrinogen, respectively: J. S. Bennett, C. Chan, G. Vilaire, S. A. Mousa, W. F. DeGrado, J. Biol. Chem. 1997, 272, 8137-8140.
26. 3 binding.